MARTIN MARIETTA MATERIALS INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $MLM in the last 30 days.
See all $MLM insider activity →Citigroup maintained a 'Buy' rating for Martin Marietta Materials (MLM) but lowered its price target to $610 from $690. The company's stock is currently trading at $484.01, with a GF Value™ of $634.49, indicating it is 23.7% undervalued. MLM has a strong GF Score™ of 90/100, reflecting robust growth and profitability, but moderate financial strength.
Martin Marietta Materials' (MLM) average price target lowered to $656.04 by 23 analysts, down from $659.52, with a range of $556 to $800. This implies a 37% upside from the Sep. 30 closing price. The consensus rating remains 'Buy' across 27 analysts, with 17 Buys, 9 Holds, and 1 Sell.
MARTIN MARIETTA MATERIALS INC (MLM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement On September 15, 2026, Martin Marietta Materials, Inc., (the “Corporation”) and its wholly - owned subsidiary, Martin Marietta Funding LLC (“MM Funding”), entered into the Eighteenth Amendment (the “Eighteenth Amendment”) to i
Over the past 7 days, AlphAI's AI scored 1 news story mentioning MLM (MARTIN MARIETTA MATERIALS INC). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent MLM coverage spans financial news, mergers & acquisitions and sector analysis.
Target reduction suggests a more modest outlook, likely pressuring the stock lower.
The slight price‑target cut may temper bullish sentiment and could lead to modest selling pressure.
The amendment improves liquidity flexibility and may lower financing costs for MLM.
Potential revenue boost from added lime capacity and synergies with existing operations.
Large‑scale acquisition expands product mix and should improve margins, supporting a bullish outlook.
AlphAI scores every news story that mentions MLM with an AI model for sentiment and relevance, and aggregates insider trades from MARTIN MARIETTA MATERIALS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Citigroup maintained a 'Buy' rating for Martin Marietta Materials (MLM) but lowered its price target to $610 from $690. The company's stock is currently trading at $484.01, with a GF Value™ of $634.49, indicating it is 23.7% undervalued. MLM has a strong GF Score™ of 90/100, reflecting robust growth and profitability, but moderate financial strength.
2 min readMartin Marietta Materials' (MLM) average price target lowered to $656.04 by 23 analysts, down from $659.52, with a range of $556 to $800. This implies a 37% upside from the Sep. 30 closing price. The consensus rating remains 'Buy' across 27 analysts, with 17 Buys, 9 Holds, and 1 Sell.
1 min readMARTIN MARIETTA MATERIALS INC (MLM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement On September 15, 2026, Martin Marietta Materials, Inc., (the “Corporation”) and its wholly - owned subsidiary, Martin Marietta Funding LLC (“MM Funding”), entered into the Eighteenth Amendment (the “Eighteenth Amendment”) to i
2 min readCarmeuse acquired 80% of Argentina's Caleras San Juan, expanding lime production capacity. Mississippi Lime Company partnered with Fortera for low-carbon cement. SigmaRoc bought Dolomitas in Lithuania for €118m. Martin Marietta completed its acquisition of Lhoist North America. Breedon Group and Votorantim Cimentos España announced executive appointments. US removed tariffs on Canadian cement imports. Heidelberg Materials plans to close its Ranville plant in France.
3 min readJ.P. Morgan recommends Reformation (REF) and Martin Marietta Materials (MLM) as investment opportunities. REF, a sustainable fashion company, reported Q2 revenue of $155.2M, up 24%, and has a $21 price target. MLM, a construction materials supplier, completed a $13.5B acquisition and reported Q2 revenue of $1.9B, up 21%. Both stocks have positive analyst ratings.
2 min readMartin Marietta Materials (MLM) faces challenges from weaker construction demand and rising costs, with potential share dilution from the Lhoist North America acquisition. Analysts project $8.8B revenue and $1.6B earnings by 2029, but risks include higher leverage and margin pressure. Current net margin is 13.9%, down from 16.1%.
3 min readHigh-grade debt issuance surged to $57 billion in the first two days of September, potentially leading to a fourth consecutive monthly record. September's supply could exceed $200 billion, surpassing last year's $189 billion. Key deals include GlaxoSmithKline's $6.5 billion offering and UBS's $6 billion print. AI debt spreads remain tight, but yields have risen. M&A-related debt issuance increased to 20% in August, the highest since May.
3 min readAnalysts upgraded five companies: Barclays raised Sagimet Biosciences (SGMT) to Overweight, targeting $18. B of A upgraded Figure Technology (FIGR) to Neutral, targeting $49. UBS upgraded Illumina (ILMN) to Buy, targeting $260. Wells Fargo upgraded Martin Marietta (MLM) to Overweight, targeting $609. UBS also upgraded Waters (WAT) to Buy, targeting $490.
1 min readWells Fargo upgraded Martin Marietta Materials (MLM) to Overweight, raising its price target to $609 from $581. The company's stock is trading at $511.44, 24.2% below its GF Value™ of $674.78, indicating undervaluation. MLM has a GF Score™ of 90/100, reflecting strong growth and profitability. The upgrade follows MLM's $13.5 billion acquisition of Lhoist North America, expected to drive margin expansion.
2 min readAnalysts made several rating changes: TD Cowen initiated Faeth Therapeutics as buy, Barclays upgraded Sagimet Biosciences to overweight, JPMorgan upgraded Lithium Americas to overweight, and more. Price targets were also adjusted for companies like Affirm, Robinhood, and First Solar.
3 min read
